Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies

Tumor-infiltrating lymphocytes (TILs) have potential value for stratifying the treatment of breast cancer (BC), though their precise use remains unclear. We aimed to investigate the utility of TILs using an alternative approach in different settings. We reviewed patients with triple-negative (TN) or...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Breast Cancer Res Treat
Prif Awduron: Hida, Akira I., Sagara, Yasuaki, Yotsumoto, Daisuke, Kanemitsu, Shuichi, Kawano, Junko, Baba, Shinichi, Rai, Yoshiaki, Oshiro, Yumi, Aogi, Kenjiro, Sagara, Yoshiaki, Ohi, Yasuyo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Springer US 2016
Pynciau:
Preclinical Study
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937092/
https://ncbi.nlm.nih.gov/pubmed/27260189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3848-2
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg